Trans-Radial Coronary Interventions Using A Sheathless Guiding Catheter
Sheathless-TRI
Trans-Radial Percutaneous Coronary Interventions Using a Sheathless Guiding Catheter-Based Approach
1 other identifier
interventional
250
1 country
1
Brief Summary
Background: The transradial approach is increasingly used in percutaneous coronary intervention (PCI) because of lower major access site complications, lower bleeding risk and earlier patient mobilization. According to this trend, in the last couple of years at the University Hospital of Geneva the investigators have changed their practice and currently the transradial approach is the most frequently used for PCI. However, the small diameter of the radial artery remains a major limitation of the technique, especially in women or for complex PCI necessitating larger bore guiding catheters. This may be overcome with sheathless guiding catheters (Asahi, Japan), allowing for a standard inner catheter diameter (6-7 Fr), with an outer diameter equivalent to a standard 5 and 6 Fr introducer sheath. Aim: This study is aimed to compare the transradial approach for PCI with a sheathless guiding catheter and with a standard guiding catheter in women and patients with complex lesion necessitating large bore guiding catheters. Material and methods: This prospective study will consecutively randomize all women and all men with bifurcation/ostial lesion of a major coronary vessel (i.e. ≈ 120/year) in whom a transradial PCI is attempted. The procedures will be performed either with a standard 6 or 7Fr guiding catheter or with the sheathless 6.5, 7.5 Fr catheters. End-points: Successful performance a transradial PCI in all consecutive patients which qualify according to the inclusion criteria (technical feasibility). Establish the proportion of procedures performed with no device-related complications (safety). Analyze in details the technical aspects of the sheathless catheter (efficacy). Sample size: The investigators have planed to include in the study ≈ 250 patients in two years. After 1 year of enrollment the investigators will perform an interim analysis and the instigators will decide at that moment, according to the observed end-points, if prolonging the study would be of any scientific value. In this case another 100 patients will be further included in the study. Enrollment time: The investigators will start the study as soon the local ethical committee will give us the permission. The investigators plan to start the study in July 2010. The end is expected for July 2012.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2 coronary-artery-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2010
CompletedFirst Submitted
Initial submission to the registry
August 23, 2010
CompletedFirst Posted
Study publicly available on registry
April 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2013
CompletedMarch 6, 2013
March 1, 2013
3.1 years
August 23, 2010
March 5, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Procedural success
Procedural success, defined as a successful delivery of the stent using the sheathless guding catheter, in consecutive patients according to the inclusion criteria (women and bifurcation/ostial lesions) = technical feasibility of the sheathless catheter.
baseline
Procedural safety
Procedural safety, defined as the proportion of procedures performed in the absence of device-related complications (= safety of the sheathless catheter).
baseline
Procedural safety
Procedural safety, defined as the proportion of procedures performed in the absence of device-related complications (= safety of the sheathless catheter).
+24 hours
Secondary Outcomes (2)
Safety and Tolerability
baseline
safety and tolerability
+24 hours
Study Arms (2)
Sheathless group
EXPERIMENTALpatient randomized to the sheathless guiding catheter group
Conventional group
ACTIVE COMPARATORpatients randomized to the conventional guiding catheter group
Interventions
Eligibility Criteria
You may qualify if:
- Patients need to be at least 18 years old.
- Patients presenting with a significant coronary artery disease who qualify for PCI and who can be treated by a radial approach.
- Any women requiring PCI who can be treated by a radial approach.
- Any patients with a bifurcation lesion or the ostial lesion of the left anterior descending (LAD) and/or left circumflex artery (LCX), lesions commonly treated with a 7 Fr guiding catheter.
- Bifurcation lesion = any lesion of a main epicardial vessel (i.e. LAD, LCX, right coronary artery) involving at least one major side branch (i.e. diagonal or marginal branches).
- Ostial lesion of the LAD or LCX = presence of a significant stenosis \<5mm from the distal part of the left main.
You may not qualify if:
- Patients who refused to give their written informed consent.
- Male patients, in whom PCI can be easily performed with a 6 Fr standard guiding catheter (i.e. no bifurcation or ostial lesion).
- Patients in whom the radial approach is contra-indicated:
- Patients with a dialysis arteria-venous fistula or in whom an arteria-venous fistula is planed in the future.
- Patients with a known radial artery occlusion.
- Patients in whom a radial approach was unsuccessfully already attempted in the past (anamnestic notion or previous medical record) secondary to a:
- Challenging vessel anatomy,
- Vessel tortuosity,
- Known impossibility to cannulate the coronary ostia by the radial approach.
- Patients in whom the Allen test results pathological bilaterally:
- In case of pathological Allen test in one hand the other hand will be tested before choosing the femoral approach.
- Patients in whom the femoral approach is adopted as primary catheterization approach (at interventionist's discretion), including:
- Unstable patients (myocardial infarction, cardiogenic shock).
- Patients necessitating femoral access for an intra-aortic balloon counterpulsation
- Patients presenting with a double mammary coronary graft (right and left internal mammary utilized for by-pass grafts).
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University hospital
Geneva, Canton of Geneva, 1211, Switzerland
Related Publications (2)
Mamas MA, Fath-Ordoubadi F, Fraser DG. Atraumatic complex transradial intervention using large bore sheathless guide catheter. Catheter Cardiovasc Interv. 2008 Sep 1;72(3):357-364. doi: 10.1002/ccd.21637.
PMID: 18727126BACKGROUNDMamas M, D'Souza S, Hendry C, Ali R, Iles-Smith H, Palmer K, El-Omar M, Fath-Ordoubadi F, Neyses L, Fraser DG. Use of the sheathless guide catheter during routine transradial percutaneous coronary intervention: a feasibility study. Catheter Cardiovasc Interv. 2010 Mar 1;75(4):596-602. doi: 10.1002/ccd.22246.
PMID: 20049959BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
August 23, 2010
First Posted
April 1, 2011
Study Start
August 1, 2010
Primary Completion
September 1, 2013
Last Updated
March 6, 2013
Record last verified: 2013-03